¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty acid activation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid mucopolysaccharide
    »ê¼ºÁ¡¾×´Ù´ç·ù, »ê¼º¹ÂÄÚ´Ù´ç·ù
  • acid phosphatase
    »ê¼ºÀλêºÐÇØÈ¿¼Ò
  • acid pyuria
    »ê¼º°í¸§´¢, »ê¼º³ó´¢
  • acid radical
    »ê±â, »ê¶óµðÄ®
  • acid rain
    »ê¼ººñ
  • acid salt
    »ê¿°
  • acid therapy
    »ê¿ä¹ý
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÁö½Ã°è
  • acid-fast
    Ç×»ê-
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast organism
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • aliphatic amino acid
    Áö¹æ¾Æ¹Ì³ë»ê
  • allokainic acid
    ¾Ë·ÎÄ«Àλê
  • amino acid
    ¾Æ¹Ì³ë»ê
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • aminohippuric acid
    ¾Æ¹Ì³ë¸¶´¢»ê
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arsenic acid
    ºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê
  • benzoic acid
    º¥Á¶»ê
  • bile acid
    ´ãÁó»ê
  • boric acid
    ºØ»ê
  • butyric acid
    ºÎƼ¸£»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Hydroxybutyric acid
    ÇÏÀ̵å·ÎºÎÆ¿»ê
  • Kainate amino acid receptor
    Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
  • Lactic acid = lactate
    ¶ôÆ®»ê(¡­ß«),Á¥»ê(¡­ß«)
  • Lactic acid dehydrogenase
    ¶ôÆ® »êÅ»¼ö¼ÒÈ¿¼Ò(¡­ß«÷­â©áÈý£áÈ)
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p- ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • N-Formiminoglutamic acid
    N-Æ÷¸§À̹̳ë±Û·çŽ»ê
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA=£¾ribonucleic acid
    ¸®º¸ÇÙ»ê.
  • VMA =>vanillymandelic acid
    ¹Ù´Ò¸¸µ¥¸¯»ê
  • Van Slyke amino acid procedure
    ¹Ý½½¶óÀÌÅ©¾Æ¹Ì³ë»ê¹æ¹ý
  • abietolic acid
    ¾Æºñ¿¡Åç»ê.
  • acetic acid
    ¾Æ¼¼Æ®»ê, ÃÊ»ê(õ³ß«).
  • acetic acid
    ¾Æ¼¼Æ®»ê
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê.
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • atherosclerosis,fatty sterak
    Áö¹æ¼±Á¶(ò·Û¸¼±Á¶)
  • blown fatty oil
    ÃëÀÔÁö¹æÀ¯(ö£ ò·Û¸êú).
  • essential fatty acids
    ÇʼöÁö¹æ»ê.
  • fatty
    Áö¹æ(ò·Û¸)ÀÇ.
  • fatty acids
    Áö¹æ»ê
  • fatty cast
    Áö¹æ¿øÁÖ(ò·Û¸ê­ñº)
  • fatty change
    Áö¹æ º¯¼º(¡­Ü¨à÷)
  • fatty compound
    Áö¹æÁ·È­ÇÕ¹°(¡­ðéûùùêÚª).
  • fatty concrement
    Áö¹æ°á¼®(¡­Ì¿à´).
  • fatty corneal degeneration
    Áö¹æ°¢¸·º¯¼º
  • fatty diarrhea
    Áö¹æ¼º ¼³»ç.
  • fatty exudate
    Áö¹æ»ïÃâ¹°, °æ¼º»ïÃâ¹°
  • fatty food intolerance
    Áö¹æ½ÄºÒ³»¼º(¡­ãÝÝÕÒ±àõ).
  • fatty ingrowth
    Áö¹æ ħÀ±(¡­öÙëÈ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid casein
    »ê(ß«)ÄÉÀ̽Å
  • acid hematin
    »ê(ß«)Ç츶ƾ
  • acid number
    »êÄ¡(ß«ö·)
  • acid pH
    »ê¼º(ß«àõ) pH
  • acid phosphatase
    »ê¼º(ß«àõ) Æ÷½ºÆÄÅ×À̽º
  • acid-ammonia ligase
    »ê(ß«)¾Ï¸ð´Ï¾Æ ¶óÀ̰ÔÀ̽º
  • acid-base balance
    »ê¿°±â±ÕÇü (ß«ç¤Ðñгû¬)
  • acid-base catalyst
    »ê¿°±âÃ˸Š(ß«ç¤ÐñõºØÚ)
  • acid-base equilibrium
    »ê¿°±âÆòÇü (ß«ç¤ÐñøÁû¬)
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à (ß«ç¤Ðñò¦ãÆå·)
  • acid-base titration
    »ê¿°±â ÀûÁ¤ (ß«ç¤ÐñîêïÒ)
  • acid-citrate-dextrose solution
    »ê(ß«)-½ÃÆ®¸£»ê-(ß«)µ¦½ºÆ®·Î½º ¿ë¾×(éÁäû)
  • acid-fast
    Ç׻꼺 (ù÷ß«àõ)
  • acid-thiol ligase
    »ê(ß«)ŸÀ̿öóÀ̰ÔÀ̽º
  • acidic amino acid
    »ê¼º(ß«àõ)¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FAEES fatty acid ethyl ester synthase
FAF fatty acid free; fibroblast-activating factor
FAME fatty acid methyl ester
FAS fatty acid synthetase; Federation of American Scientists; fetal alcohol syndrome
FFA Fellow of the Faculty of Anaesthetists; free fatty acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FAT Fatty acid translocase
FATP Fatty acid transport protein
FFA Free fatty acid
H-FABP Heart fatty acid binding protein
H-FABP Heart-type Fatty Acid Binding Protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid fast staining
    Ç×»ê ¿°»ö
  • acid food
    »ê¼º ½Äǰ
    ¿¬¼ÒÇßÀ» °æ¿ì¿¡ ȸºÐ¿¡ À½À̿ ¼ººÐÀÌ ¸¹±â ¶§¹®¿¡ »ê¼ºÀ» º¸ÀÌ´Â ½ÄǰÀÌ´Ù. °î·ù, À°·ù µîÀº Cl, S, P µîÀÇ ¿ø¼Ò¸¦ ¸¹ÀÌ ÇÔÀ¯Çϱ⠶§¹®¿¡ ü³»¿¡¼­ ¿¬¼Ò ºÐÇØµÇ¸é »ê¼ºÀ¸·Î ±â¿î´Ù. ½Äǰ 100gÀ» ¿¬¼Ò½ÃÄѼ­ »ý¼ºµÈ ȸºÐÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ 1±ÔÁ¤ÀÇ ¾ËÄ®¸® ¿ë·®À¸·Î ±× Á¤µµ¸¦ Ç¥½ÃÇÑ´Ù.
  • acid gel
    Á©Çü »ê
  • acid intoxication
    »ê Áßµ¶, »ê Áßµ¶Áõ
  • acid mucopolysaccharide
    »ê¼º Á¡¾× ´Ù´ç·ù
  • acid phosphatase assay
    »ê¼º Æ÷½ºÆÄŸÁ¦ ÃøÁ¤
  • acid radical
    »ê±â
    À¯±â, ¹«±âÀÇ °¢Á¾ »êÀÇ ºÐÀڷκÎÅÍ ¼ö¼Ò ÀÌ¿ÂÀ¸·Î¼­ ÀÌ¿ÂÈ­ ÇÒ ¼ö ÀÖ´Â ¼ö¼Ò ¿øÀÚ¸¦ ÇÑ °³ ÀÌ»ó ¶¼¾î ³½ ³ª¸ÓÁö ¿øÀÚ ¶Ç´Â ¿øÀÚ´Ü.
  • acid spring
    »ê¼º õ
    ¹° 1kg ¼Ó¿¡ ¼ö¼ÒÀ̿ 1mg ÀÌ»óÀ» ÇÔÀ¯Çϸç À½À̿°ú Á¶ÇÕ½ÃŰ¸é ¿°»êÀ̳ª Ȳ»ê°ú °°Àº À¯¸® ±¤»êÀ» ±¸¼ºÇÑ´Ù. ÀϺ» µî È­»êÀÌ ¸¹Àº ³ª¶óÀÇ Æ¯À¯ÇÑ ¿ÂõÀ̸ç, ºÐÈ­±¸, ºÐ±â°ø ±Ùó¿¡¼­ ¼Ú¾Æ ³ª¿À´Â ÀÏÀÌ ¸¹°í, ÀϹÝÀûÀ¸·Î °í¿ÂÀÌ´Ù. Ȳȭ¼ö¼Ò, ¸í¹Ý, ³ì¹Ý µîÀ» µ¿½Ã¿¡ ÇÔÀ¯Çϰí ÀÖ´Ù. ÇǺÎÀÇ ÀÚ±ØÀÌ °­Çϰí Áþ¹«¸§ÀÌ ÀϾ±â ½¬¿ì¹Ç·Î ÇǺο°¿¡ ÁÖÀÇÇÑ´Ù.
  • acid tide
    »êÁõ°¡±â
    ÀϽÃÀûÀ¸·Î ¿äÀÇ »êµµ°¡ Áõ°¡ÇÏ´Â Çö»ó.
  • acid value
    »ê°ª, »ê°¡
    À¯Áö 1g¿¡ ÇÔÀ¯µÈ À¯¸® Áö¹æ»êÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ ¼ö»êÈ­Ä®·ýÀÇ §·¼ö¸¦ »ê°¡¶ó ÇÑ´Ù. À¯Áö´Â ¿À·¡ µÇ¸é À¯¸® Áö¹æ»êÀÌ Áõ°¡ÇϹǷΠ½Å¼±µµ µîÀÇ ±âÁØÀÌ µÈ´Ù. ½Ä¿ëÀ¯Áö´Â »ê°¡ 1 ÀÌÇÏÀÇ °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù°í ÇÑ´Ù.
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • acid-fast nonmotile rod
    Ç׻꼺 ºñ¿îµ¿¼º °£±Õ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
enzyme activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1) activation by ions (activators); 2) activation by cofactors (coenzymes); and 3) conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
(12 Dec 1998)
juxtacrine activation Activation of target cells by membrane anchored growth factors, also used for activation of leucocytes by PAF bound to endothelial cell surface.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feed-forward activation The activation of an enzyme by a precursor of the substrate of that enzyme.
(05 Mar 2000)
upstream activation site A DNA sequence that regulates transcription like an enhancer but does notwork if its located downstream from a promoter.
(09 Oct 1997)
low-activation materials <radiobiology> In fission reactors, one is forced to deal with the radioactive byproducts of the fission process, but in fusion reactors one generally has a choice of what materials to expose to neutrons produced by the fusion process. A major problem for fusion reactors is developing materials (such as for the reactor vacuum vessel structure) which can be exposed to high levels of neutron bombardment without becoming permanently radioactive. Candidate structural materials which have relatively low induced radiactivation (generally relative to stainless steel) are known as low-activation materials, these include titanium, vanadium, and silicon-carbide.
(09 Oct 1997)
lymphocyte activation <haematology> The change in morphology and behaviour of lymphocytes exposed to a mitogen or to an antigen to which they have been primed. The result is the production of lymphoblasts, cells that are actively engaged in protein synthesis and that divide to form effector populations. Should not be confused with transformation of the type associated with oncogenic viruses and activation is therefore perhaps a better term.
(18 Nov 1997)
monounsaturated fatty acids A fatty acid chain with at least two empty spaces that could be hydrogenated (have a hydrogen atom added). Saturated (hydrogenated) fatty acids are a greater health risk for the development of atherosclerotic vascular disease.
(27 Sep 1997)
saturated fatty acids In eukaryotic membranes refers to stearic, palmitic and myristic acids, that are linear aliphatic chains with no double bonds. Prokaryotes have numerous branched chain saturated fatty acids.
(18 Nov 1997)
omega 3 fatty acids A class of fatty acids that have a double bond three carbons from the methyl moiety; reportedly, they play a role in lowering cholesterol and LDL levels.
Synonym: omega-3 fatty acids.
(05 Mar 2000)
fatty Containing fat, or having the qualities of fat; greasy; gross; as, a fatty substance.
<medicine> Fatty acid, a tumour consisting of fatty or adipose tissue; lipoma.
Source: Websters Dictionary
(01 Mar 1998)
fatty acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated).
(12 Dec 1998)
fatty acids, essential Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids.
(12 Dec 1998)
fatty acids, monounsaturated Fatty acids which are unsaturated in only one position.
(12 Dec 1998)
fatty acids, nonesterified The fraction of plasma fatty acids that are not in the form of glycerol esters. They are also called free fatty acids, but this is a misnomer because they are transported complexed with albumin.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hypophosphorous acid
    Â÷¾ÆÀλê
  • indoleacetic acid
    Àε¹ÃÊ»ê(½Ä¹°ÀÇ ¼ºÀå È£¸£¸ó)
  • inosinic acid
    À̳ë½Å»ê
  • iodic acid
    ¿ä¿Àµå»ê
  • isonicotinic acid hydrazide
    (¾à)À̼ҴÏÄÚÆ¾»ê ÇÏÀ̵å¶óÁöµå(°áÇÙ Ä¡·áÁ¦)
  • lactic acid
    À¯»ê
  • maleci acid
    ¸»·¹»ê
  • malic acid
    (È­) »ç°ú»ê
  • margaric acid
    ¸¶¸£°¡¸£»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • muriatic acid
    ¿°»ê
  • naildixic acid
    (È­)³¯¸®µñ½Å»ê(ºñ´¢,»ý½Ä±â °¨¿°Áõ Ä¡·á¿ë Ç×»ý¹°Áú)
  • nitric acid
    Áú»ê
  • nitrous acid
    ¾ÆÁú»ê
  • nucleic acid
    (»ýÈ­)ÇÙ»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á